Abstract
This review is focused on literature data and our own research of the nontrivial quinoid pathway for the oxidation of adrenaline. All catecholamines can be oxidized similarly with formation of corresponding aminochromes. This process is simulated in vitro in an alkaline medium and is known as the adrenaline autoxidation chain reaction, whose products are adrenochrome and radical compounds, superoxide anions (\({\text{O}}_{2}^{{ - {\kern 1pt} \centerdot }}\)), and other. This reaction was previously used to determine the activity of superoxide dismutase as a model of superoxide generation. We have proposed various new methodical approaches that allow the determination of the enzyme activity and reveal the anti/prooxidant properties of various compounds and materials. This pathway of conversion of one of the catecholamines (dopamine) is currently described as a “preclinical model of Parkinson’s disease.” In this regard, we have proposed the reaction of adrenaline autoxidation to be used in search for substances that can inhibit the process of quinoid oxidation, that is, to identify potential neuroprotective agents. Experimental and theoretical studies of this reaction expand the understanding of the mechanisms of free radical processes that occur in the body.

This publication has 52 references indexed in Scilit: